Posts by: Patricia Inacio, PhD

Lung Cancer, News

Laboratory Corporation of America Holdings (LabCorp), a leading healthcare diagnostics company, announced that the FDA has approved a new diagnostic test for patients with non-small cell lung cancer (NSCLC). The test was used ... Read more

October 12, 2015November 5, 2015

Researchers Discover KLF4 is a Crucial Factor in Pulmonary Hypertension

News, Pulmonary Hypertension

In a new study entitled “Smooth muscle cell progenitors are primed to muscularize in pulmonary hypertension,” a team of researchers at the Yale Cardiovascular Research Center discovered unique smooth muscle ... Read more

October 5, 2015November 5, 2015

Anthera Pharmaceuticals Announces Start of Cystic Fibrosis Patient Recruitment For SOLUTION Clinical Trial

Cystic Fibrosis, News

Anthera Pharmaceuticals, Inc. announced that it is actively recruiting participants for its new Phase 3 clinical study on Cystic Fibrosis, called SOLUTION (Study of Oral Liprotamase Unit-Matched Therapy Of Non-Porcine Origin). ... Read more

September 16, 2015November 9, 2015

UMEC/VI Fixed-Dose Bronchodilator is as Efficient as other Bronchodilator Therapies in COPD

COPD, News

In a new study entitled “Comparative efficacy of combination bronchodilator therapies in COPD: a network meta-analysis,” authors performed a comparative analysis of the efficacy of umeclidinium and vilanterol bronchodilator fixed-dose, ... Read more

September 8, 2015November 6, 2015

Discovered Mechanism Underlying “Farm Dust” Could Lead To Protection Against Asthma

Asthma, News

In a new study entitled “Farm dust and endotoxin protect against allergy through A20 induction in lung epithelial cells” a team of researchers identified the link underlying the known protective ... Read more

September 7, 2015November 6, 2015

Roflumilast Reduces Airway Inflammation in Asthma Patients

Asthma, News

In a new study entitled “Roflumilast for asthma: Efficacy findings in mechanism of action studies,” researchers evaluated the potential therapeutic effects of roflumilast, a treatment used in patients with severe chronic ... Read more

September 4, 2015November 5, 2015

Inflammatory TNF-alpha Found To Prevent Degradation of CFTR Protein in Cystic Fibrosis

Cystic Fibrosis, News

In a new study entitled “An unexpected effect of TNF-α on F508del-CFTR maturation and function,” researchers found that a key factor released during inflammatory responses – TNF-alpha – can prevent ... Read more

August 20, 2015November 6, 2015

Asthma Treatment Found To Be More Efficient When Targeting Two Cytokine Subsets

Asthma, News

In a new study entitled “TH2 and TH17 inflammatory pathways are reciprocally regulated in asthma,” authors suggest that asthma patients can be divided into three clusters, according to the expression ... Read more

August 19, 2015August 19, 2015

Atezolizumab Immunotherapy Found To Decrease NSCLC Tumors

Lung Cancer, News

Genentech recently announced the results of a Phase II study entitled BIRCH for the investigational cancer immunotherapy atezolizumab (MPDL3280A; anti-PDL1). Primary endpoints for BIRCH study investigating the therapeutic benefit of atezolizumab in patients ... Read more

August 17, 2015November 5, 2015

Cystic Fibrosis Microbes Found To Adapt to Dynamic Chemical Sputum Environments

Cystic Fibrosis, News

In a new study entitled “Pediatric Cystic Fibrosis Sputum Can Be Chemically Dynamic, Anoxic, and Extremely Reduced Due to Hydrogen Sulfide Formation,” researchers discovered that cystic fibrosis-associated microorganisms are capable of ... Read more